Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | RAR-related orphan receptor C | Starlite/ChEMBL | References |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | o-methyltransferase | 0.0062 | 0.0359 | 0.0875 |
Brugia malayi | O-methyltransferase family protein | 0.0062 | 0.0359 | 0.0281 |
Brugia malayi | glutaminase DH11.1 | 0.027 | 0.4103 | 0.5209 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0127 | 0.1532 | 0.1725 |
Schistosoma mansoni | o-methyltransferase | 0.0062 | 0.0359 | 0.0875 |
Entamoeba histolytica | protein kinase, putative | 0.0099 | 0.103 | 0.5 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0114 | 0.1302 | 0.1466 |
Brugia malayi | O-methyltransferase family protein | 0.0062 | 0.0359 | 0.0281 |
Mycobacterium tuberculosis | Probable methyltransferase | 0.0062 | 0.0359 | 0.0404 |
Trichomonas vaginalis | glutaminase, putative | 0.027 | 0.4103 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.027 | 0.4103 | 1 |
Wolbachia endosymbiont of Brugia malayi | O-methyltransferase | 0.0062 | 0.0359 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0127 | 0.1532 | 0.1725 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.005 | 0.0146 | 0.5 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.005 | 0.0146 | 0.0164 |
Mycobacterium tuberculosis | Probable L-lysine-epsilon aminotransferase Lat (L-lysine aminotransferase) (lysine 6-aminotransferase) | 0.0472 | 0.7743 | 0.8716 |
Schistosoma mansoni | hypothetical protein | 0.018 | 0.2479 | 0.6041 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0114 | 0.1302 | 0.1466 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 0.0153 | 0.0374 |
Loa Loa (eye worm) | IRE protein kinase | 0.0099 | 0.103 | 0.2235 |
Trichomonas vaginalis | serine threonine-protein kinase, putative | 0.0051 | 0.0153 | 0.0374 |
Onchocerca volvulus | 0.0062 | 0.0359 | 0.5 | |
Schistosoma mansoni | o-methyltransferase | 0.0062 | 0.0359 | 0.0875 |
Echinococcus multilocularis | serine:threonine protein kinase:endoribonuclease | 0.0099 | 0.103 | 0.4155 |
Plasmodium vivax | thioredoxin reductase, putative | 0.005 | 0.0146 | 1 |
Leishmania major | trypanothione reductase | 0.005 | 0.0146 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase:endoribonuclease | 0.0099 | 0.103 | 0.4155 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0114 | 0.1302 | 0.1466 |
Plasmodium vivax | glutathione reductase, putative | 0.005 | 0.0146 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0127 | 0.1532 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0114 | 0.1302 | 0.1466 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0127 | 0.1532 | 0.1725 |
Plasmodium falciparum | glutathione reductase | 0.005 | 0.0146 | 1 |
Brugia malayi | O-methyltransferase family protein | 0.0062 | 0.0359 | 0.0281 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.005 | 0.0146 | 0.0587 |
Brugia malayi | O-methyltransferase | 0.0062 | 0.0359 | 0.0281 |
Loa Loa (eye worm) | O-methyltransferase | 0.0062 | 0.0359 | 0.0539 |
Echinococcus granulosus | geminin | 0.018 | 0.2479 | 1 |
Schistosoma mansoni | hypothetical protein | 0.018 | 0.2479 | 0.6041 |
Schistosoma mansoni | glutaminase | 0.027 | 0.4103 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0114 | 0.1302 | 0.1466 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.005 | 0.0146 | 0.0587 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0042 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.0359 | 0.0539 |
Brugia malayi | Ribonuclease 2-5A family protein | 0.0099 | 0.103 | 0.1164 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0051 | 0.0159 | 0.0387 |
Mycobacterium ulcerans | glutaminase | 0.027 | 0.4103 | 0.4103 |
Mycobacterium leprae | PROBABLE METHYLTRANSFERASE | 0.0062 | 0.0359 | 0.2343 |
Mycobacterium ulcerans | L-lysine aminotransferase | 0.0472 | 0.7743 | 0.7743 |
Entamoeba histolytica | protein kinase, putative | 0.0099 | 0.103 | 0.5 |
Echinococcus multilocularis | geminin | 0.018 | 0.2479 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0114 | 0.1302 | 0.1466 |
Mycobacterium ulcerans | methyltransferase | 0.0062 | 0.0359 | 0.0359 |
Toxoplasma gondii | thioredoxin reductase | 0.005 | 0.0146 | 1 |
Mycobacterium tuberculosis | Probable catechol-O-methyltransferase | 0.0536 | 0.8883 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.005 | 0.0146 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.005 | 0.0146 | 0.5 |
Loa Loa (eye worm) | glutaminase | 0.027 | 0.4103 | 1 |
Onchocerca volvulus | 0.0062 | 0.0359 | 0.5 | |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0114 | 0.1302 | 0.85 |
Schistosoma mansoni | o-methyltransferase | 0.0062 | 0.0359 | 0.0875 |
Brugia malayi | 4-aminobutyrate aminotransferase, mitochondrial precursor | 0.0472 | 0.7743 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
%max (binding) | = 102 % | Inhibition of N-(2-chloro-6-fluorobenzyl)-N-((2'-methoxy-[1,1'-biphenyl]-4-yl)methyl)benzenesulfonamide-induced APC-labeled RORgammat receptor ligand binding domain (unknown origin) after 1 hr by FRET assay | ChEMBL. | 24388993 |
IC50 (binding) | = 6.1 | Inhibition of RORgammat receptor ligand binding domain in mouse spleen CD4+ T cells assessed as inhibition of IL-17 production after 3 days by ELISA | ChEMBL. | 24388993 |
IC50 (binding) | = 7.4 | Inhibition of APC-labeled RORgammat receptor ligand binding domain (unknown origin) after 1 hr by FRET assay | ChEMBL. | 24388993 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.